About the Vice Chancellor
Dr. Michael Pazzani
Vice Chancellor for Research and Economic Development
Dr. Michael J. Pazzani is Vice Chancellor for Research and Economic Development at University of California, Riverside. His responsibilities at UCR include oversight of research, external funding for research, corporate partnerships and technology commercialization. Dr. Pazzani is also a Professor of Computer Science. He has published over 150 papers on machine learning, knowledge discovery from databases, personalization, internet search, and recommendation systems. He serves on the Editorial Board of Machine Learning. He is a Fellow of the Association for the Advancement of Artificial Intelligence. In 2014, a paper Dr. Pazzani and his students authored in 1996, was selected as the AAAI Classic paper award. Dr. Pazzani's research has been funded by the National Science Foundation, the U.S. Department of Education, DARPA, AFOSR, ARO, and several companies including SAIC, Hughes Aircraft, Qualcomm, NYNEX, and Touchstone Software. He received his Ph.D. in Computer Science from UCLA and was an assistant, associate and full professor at the University of California, Irvine, where he also served as Chair of Information and Computer Science.
Dr. Pazzani comes to UCR from Rutgers, the State University of New Jersey where he was Vice President of Research and Economic Development. Prior to his appointment at Rutgers, Dr. Pazzani was the Director of the Information and Intelligent Systems Division at the National Science Foundation from 2002-2006 where he oversaw a research budget of $200M. In addition, Dr. Pazzani coordinated NSF's homeland security research. He also served as a member on the Board of Regents of the National Library of Medicine at the National Institutes of Health from 2003-2005.
Dr. Pazzani was a founder of AdaptiveInfo, a start-up company involved in personalization for the mobile web acquired by Versifi Technologies in 2003. Dr. Pazzani has served on the board of directors of Combichem (NASDAQ: CCHM), a start-up company involved in computational drug discovery that was purchased by DuPont. He was a member of the scientific advisory board of several companies, including Pharsight Corporation (NASDAQ: PHST), a company that enables improvements in the clinical development of therapeutic products, and TripleHop Technologies, Inc that was acquired by Oracle.
Dr. Pazzani serves on the board of